Arima Genomics’ New CEO Strategizes Commercial Growth Push News Article Jul 2 Written by Erin Davis Erin Davis Previous Previous Aventa FusionPlus based on Hi-C FFPE Sequencing Detects Fusions Genome-Wide with High Sensitivity in Solid Tumors Next Next Arima Genomics Appoints Genomics Industry Veteran Tom Willis as Chief Executive Officer and Closes $22 Million Series C Financing
Arima Genomics’ New CEO Strategizes Commercial Growth Push News Article Jul 2 Written by Erin Davis Erin Davis